{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Rimegepant%2FBHV3000", "query": { "intervention": "Rimegepant/BHV3000" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Rimegepant%2FBHV3000&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-27T01:10:51.183Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05248997", "title": "Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps" ], "interventions": [ { "name": "rimegepant 75 mg ODT", "type": "DRUG" }, { "name": "Matching placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 261, "start_date": "2022-02-17", "completion_date": "2024-04-02", "has_results": true, "last_update_posted_date": "2025-03-26", "last_synced_at": "2026-09-27T01:10:51.183Z", "location_count": 33, "location_summary": "La Mesa, California • Panorama City, California • Roseville, California + 24 more", "locations": [ { "city": "La Mesa", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Panorama City", "state": "California" }, { "city": "Roseville", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05248997" }, { "nct_id": "NCT03237845", "title": "Safety and Efficacy in Adult Subjects With Acute Migraines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Migraine, With or Without Aura" ], "interventions": [ { "name": "Rimegepant", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1499, "start_date": "2017-07-27", "completion_date": "2018-01-31", "has_results": true, "last_update_posted_date": "2023-02-16", "last_synced_at": "2026-09-27T01:10:51.183Z", "location_count": 50, "location_summary": "Mobile, Alabama • Glendale, Arizona • Rogers, Arkansas + 44 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "La Mesa", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03237845" }, { "nct_id": "NCT05207865", "title": "Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Migraine", "Episodic Migraine", "Phonophobia", "Photophobia" ], "interventions": [ { "name": "Rimegepant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 441, "start_date": "2022-03-15", "completion_date": "2024-07-02", "has_results": true, "last_update_posted_date": "2025-09-03", "last_synced_at": "2026-09-27T01:10:51.183Z", "location_count": 19, "location_summary": "Phoenix, Arizona • Hawthorne, California • North Hollywood, California + 15 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Hawthorne", "state": "California" }, { "city": "North Hollywood", "state": "California" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05207865" }, { "nct_id": "NCT03732638", "title": "Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "Rimegepant", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1590, "start_date": "2018-11-14", "completion_date": "2021-02-02", "has_results": true, "last_update_posted_date": "2024-06-07", "last_synced_at": "2026-09-27T01:10:51.183Z", "location_count": 93, "location_summary": "Chandler, Arizona • Phoenix, Arizona • Tucson, Arizona + 86 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03732638" }, { "nct_id": "NCT05262517", "title": "Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Temporomandibular Disorders (TMD)" ], "interventions": [ { "name": "Rimegepant", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 126, "start_date": "2022-05-05", "completion_date": "2023-05-18", "has_results": true, "last_update_posted_date": "2024-05-16", "last_synced_at": "2026-09-27T01:10:51.183Z", "location_count": 32, "location_summary": "Phoenix, Arizona • Hollywood, Florida • Miami, Florida + 17 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05262517" }, { "nct_id": "NCT03461757", "title": "Trial in Adult Subjects With Acute Migraines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Migraine, With or Without Aura" ], "interventions": [ { "name": "Rimegepant", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1811, "start_date": "2018-02-27", "completion_date": "2018-10-15", "has_results": true, "last_update_posted_date": "2023-02-16", "last_synced_at": "2026-09-27T01:10:51.183Z", "location_count": 69, "location_summary": "Mobile, Alabama • Tempe, Arizona • Tucson, Arizona + 61 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03461757" }, { "nct_id": "NCT03941834", "title": "Trial for Treatment Refractory Trigeminal Neuralgia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Trigeminal Neuralgia" ], "interventions": [ { "name": "Rimegepant", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 65, "start_date": "2019-06-25", "completion_date": "2023-05-11", "has_results": true, "last_update_posted_date": "2024-06-10", "last_synced_at": "2026-09-27T01:10:51.183Z", "location_count": 20, "location_summary": "Gilbert, Arizona • La Jolla, California • Palo Alto, California + 10 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03941834" }, { "nct_id": "NCT03235479", "title": "Safety and Efficacy Study in Adult Subjects With Acute Migraines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Migraine, With or Without Aura" ], "interventions": [ { "name": "Rimegepant", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1485, "start_date": "2017-07-18", "completion_date": "2018-01-26", "has_results": true, "last_update_posted_date": "2023-02-16", "last_synced_at": "2026-09-27T01:10:51.183Z", "location_count": 50, "location_summary": "Birmingham, Alabama • Gilbert, Arizona • Tempe, Arizona + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03235479" }, { "nct_id": "NCT03266588", "title": "Open Label Safety Study in Acute Treatment of Migraine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Migraine, With or Without Aura" ], "interventions": [ { "name": "Rimegepant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3019, "start_date": "2017-08-30", "completion_date": "2019-07-15", "has_results": true, "last_update_posted_date": "2023-02-16", "last_synced_at": "2026-09-27T01:10:51.183Z", "location_count": 98, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Glendale, Arizona + 86 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03266588" }, { "nct_id": "NCT04649242", "title": "Randomized Study in Children and Adolescents With Migraine: Acute Treatment", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pediatric Migraine" ], "interventions": [ { "name": "Rimegepant/BHV3000", "type": "DRUG" }, { "name": "Matching placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 2100, "start_date": "2021-01-15", "completion_date": "2029-01-09", "has_results": false, "last_update_posted_date": "2026-09-24", "last_synced_at": "2026-09-27T01:10:51.183Z", "location_count": 169, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Tempe, Arizona + 107 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04649242" } ] }